title: Modification of Osseointegrated Device Parameters to Improve Speech in Noise and Localization Ability: Clinical Recommendations.
abstract: To determine how best to modify osseointegrated (OI) devices or environmental settings to maximize hearing performance.
  
  
  
  Prospective cohort study.
  
  
  
  Tertiary referral center.
  
  
  
  Fourteen adults with single-sided deafness (SSD) with a minimum of 6 months OI usage and nine bilaterally normal hearing controls
  
  
  
  : Speech in noise (SIN) and localization ability were assessed in a multi-speaker array (R-Space) with patients repeating sentences embedded in competing noise and verbally indicating the source speaker, respectively.
  
  
  
  SIN and localization were assessed with multiple OI microphone settings-fixed-directional, omnidirectional, and adaptive-as well as an unaided (OI off) condition. Participants completed the Abbreviated Profile of Hearing Aid Benefit questionnaire.
  
  
  
  Localization performance remains compromised for OI users with a high number of front-back confusions, but rapid learning using the fixed-directional microphone setting improved localization of sounds on the device side despite poorer localization of sounds on the normal-hearing side. SIN performance is greatly enhanced with speech presented to the contra hearing ear rather than the OI device side. Subjective report of hearing ability is highly predictive of objective SIN measures.
  
  
  
  Clinicians should consider implementing a fixed-directional microphone setting for improved localization for sounds behind the OI device, but inform patients of the trade-off in performance on the normal-hearing side. For better hearing in noise, clinicians should counsel OI recipients to orient the speech signal to their normal hearing ear rather than their OI device. The background noise subscale of the abbreviated profile of hearing aid benefit (APHAB) provides a meaningful metric by which to assess SIN performance of OI device users.
authors.affiliation: *Swedish Neuroscience Institute, Seattle, Washington, U.S.A. †Pierre-Boucher Hospital, Montreal University, Montreal, Quebec, Canada.
authors.forename: Jake
authors.initials: J
authors.lastname: Hillyer
authors.forename: P Cody
authors.initials: PC
authors.lastname: Buchanan
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Elkins
authors.forename: Stacey D
authors.initials: SD
authors.lastname: Watson
authors.forename: Francois
authors.initials: F
authors.lastname: Cloutier
authors.forename: Douglas D
authors.initials: DD
authors.lastname: Backous
authors.forename: Alexandra
authors.initials: A
authors.lastname: Parbery-Clark
mesh_terms: D000328:Adult; D000368:Aged; D001844:Bone Conduction / Q000502:physiology*; D005260:Female; D006309:Hearing; D006310:Hearing Aids; D006319:Hearing Loss, Sensorineural / Q000601:surgery; D046088:Hearing Loss, Unilateral / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009622:Noise; D016348:Osseointegration; D011446:Prospective Studies; D013067:Speech Perception; D011795:Surveys and Questionnaires